Heterologous expression, purification and functional characterization of recombinant serratiopeptidase from Serratia marcescens AD-W2
World Journal of Microbiology and Biotechnology · 2026
DOI: 10.1007/s11274-026-04795-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2026. Verfasst von Devtulya Chander und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fermentation and Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, 180001, India. Hauptthemen laut MEDLINE: Serratia marcescens, Peptide Hydrolases. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Serratiopeptidase, a proteolytic enzyme with therapeutic applications, is traditionally produced from the bacterium Serratia marcescens. Recombinant production of serratiopeptidase in Escherichia coli offers a safer alternative to the biosafety concerns of the producer. Present study involves cloning and heterologous expression of thermoactive serratiopeptidase gene from S. marcescens AD-W2 in E. coli K12 in pET28a plasmid. Optimized expression conditions i.e. 37 °C, OD600 5, 5% L-rhamnose, 5mM IPTG, and 50% dissolved oxygen led to the final yield of 190 mg/g serratiopeptidase (4747 mg protein/L within 9 h in a bioreactor. Purification and refolding of recombinant serratiopeptidase was performed in a single step using Tangential Flow Filtration (TFF) and diafiltration process. The purified recombinant serratiopeptidase exhibited specific activity of 1800 Units/mg protein, with an optimal activity at pH 9.0 and temperature 50 °C. The value of kinetic constant Km was calculated as 1.38 mg/mL for casein. The recombinant serratiopeptidase demonstrated comparable anti-inflammatory activity to the commercially available serratiopeptidase, inhibiting nitric oxide release and pro-inflammatory cytokine production in LPS-stimulated murine macrophage cell line RAW 264.7. The study reveals that the recombinant serratiopeptidase produced in E. coli K12 holds promising source of safe and effective anti-inflammatory agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fermentation and Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, 180001, India.
- Biochemical Engineering Research and Process Development Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, 180001, India.
- Fermentation and Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, 180001, India. achaubey@iiim.res.in.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. achaubey@iiim.res.in.
Zitieren
APA
Chander, D., Koul, D., Singh, S., Manhas, R. S., Kumar, D., Shukla, S., Mishra, R. P. N., Ahmed, Z., & Chaubey, A. (2026). Heterologous expression, purification and functional characterization of recombinant serratiopeptidase from Serratia marcescens AD-W2. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-026-04795-3
Vancouver
Chander D, Koul D, Singh S, Manhas RS, Kumar D, Shukla S, et al. Heterologous expression, purification and functional characterization of recombinant serratiopeptidase from Serratia marcescens AD-W2. World Journal of Microbiology and Biotechnology. 2026. doi:10.1007/s11274-026-04795-3
BibTeX
@article{Chander2026,
author = {Chander, Devtulya and Koul, Diksha and Singh, Shubham and Manhas, Ravi S and Kumar, Diljeet and Shukla, Sanket and Mishra, Ravi P N and Ahmed, Zabeer and Chaubey, Asha},
title = {Heterologous expression, purification and functional characterization of recombinant serratiopeptidase from Serratia marcescens AD-W2},
journal = {World Journal of Microbiology and Biotechnology},
year = {2026},
doi = {10.1007/s11274-026-04795-3}
}
EUVIMED